Litcius/Paper detail

Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion

Ingrid U. Scott, Paul VanVeldhuisen, Neal L. Oden, Michael S. Ip, Barbara A. Blodi

2022American Journal of Ophthalmology18 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAfliberceptVisual acuityMacular edemaBevacizumabRandomized controlled trialOphthalmologyRanibizumabEdemaOcclusionRetinal VeinClinical trialSurgeryInternal medicineChemotherapyRetinal Diseases and TreatmentsCentral Venous Catheters and HemodialysisOcular Diseases and Behçet’s Syndrome
Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion | Litcius